Transdermal dosage form for low-melting point active agent
A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the s...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Simmons, Tyler D Sivaraman, Arunprasad Cortopassi, Jeffrey E Sorenson, Adam Fieldson, Gregory T |
description | A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2013371073BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2013371073BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2013371073BB23</originalsourceid><addsrcrecordid>eNrjZLAKKUrMK05JLcpNzFFIyS9OTE9VSMsvygURCjn55bq5qTklmXnpCgX5mXklConJJZllqQpAVXklPAysaYk5xam8UJqbQcXNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDQ2Njc0MDc2MnJyJhIZQCWAzBg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Transdermal dosage form for low-melting point active agent</title><source>esp@cenet</source><creator>Simmons, Tyler D ; Sivaraman, Arunprasad ; Cortopassi, Jeffrey E ; Sorenson, Adam ; Fieldson, Gregory T</creator><creatorcontrib>Simmons, Tyler D ; Sivaraman, Arunprasad ; Cortopassi, Jeffrey E ; Sorenson, Adam ; Fieldson, Gregory T</creatorcontrib><description>A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180712&DB=EPODOC&CC=AU&NR=2013371073B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180712&DB=EPODOC&CC=AU&NR=2013371073B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Simmons, Tyler D</creatorcontrib><creatorcontrib>Sivaraman, Arunprasad</creatorcontrib><creatorcontrib>Cortopassi, Jeffrey E</creatorcontrib><creatorcontrib>Sorenson, Adam</creatorcontrib><creatorcontrib>Fieldson, Gregory T</creatorcontrib><title>Transdermal dosage form for low-melting point active agent</title><description>A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAKKUrMK05JLcpNzFFIyS9OTE9VSMsvygURCjn55bq5qTklmXnpCgX5mXklConJJZllqQpAVXklPAysaYk5xam8UJqbQcXNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDQ2Njc0MDc2MnJyJhIZQCWAzBg</recordid><startdate>20180712</startdate><enddate>20180712</enddate><creator>Simmons, Tyler D</creator><creator>Sivaraman, Arunprasad</creator><creator>Cortopassi, Jeffrey E</creator><creator>Sorenson, Adam</creator><creator>Fieldson, Gregory T</creator><scope>EVB</scope></search><sort><creationdate>20180712</creationdate><title>Transdermal dosage form for low-melting point active agent</title><author>Simmons, Tyler D ; Sivaraman, Arunprasad ; Cortopassi, Jeffrey E ; Sorenson, Adam ; Fieldson, Gregory T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2013371073BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Simmons, Tyler D</creatorcontrib><creatorcontrib>Sivaraman, Arunprasad</creatorcontrib><creatorcontrib>Cortopassi, Jeffrey E</creatorcontrib><creatorcontrib>Sorenson, Adam</creatorcontrib><creatorcontrib>Fieldson, Gregory T</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Simmons, Tyler D</au><au>Sivaraman, Arunprasad</au><au>Cortopassi, Jeffrey E</au><au>Sorenson, Adam</au><au>Fieldson, Gregory T</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Transdermal dosage form for low-melting point active agent</title><date>2018-07-12</date><risdate>2018</risdate><abstract>A drug-containing patch allows transdermal administration of a drug. The patch features a hydrophobic reservoir containing the drug, where the reservoir has a first surface and a second surface. A drug-impermeable backing overlies the first surface of the reservoir. A release sheet may overlie the second surface of the reservoir. The hydrophobic reservoir contains a drug and a hydrophobic matrix, where the hydrophobic matrix includes a hydrophobic filler in an amount which is effective to adsorb said drug; and a mixture of polyisobutylene and mineral oil. The hydrophobic matrix may contain hydrophobic colloidal silica as the hydrophobic filler. The hydrophobic reservoir layer may serve as a skin-contacting adhesive layer. Alternatively, a release-controlling adhesive layer may serve as the skin-contacting adhesive layer. The release-controlling adhesive layer may contain hydrophobic colloidal silica and a mixture of polyisobutylene and mineral oil.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2013371073BB2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Transdermal dosage form for low-melting point active agent |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A57%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Simmons,%20Tyler%20D&rft.date=2018-07-12&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2013371073BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |